Johnson & Johnson (FRA:JNJ)
Germany · Delayed Price · Currency is EUR 150.88
-1.08 (-0.71%)
Last updated: Sep 9, 2025, 5:35 PM CET
Johnson & Johnson Employees
Johnson & Johnson had 138,100 employees as of December 29, 2024. The number of employees increased by 6,200 or 4.70% compared to the previous year.
Employees
138,100
Change (1Y)
6,200
Growth (1Y)
4.70%
Revenue / Employee
€560,102
Profits / Employee
€140,052
Market Cap
363.66B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 138,100 | 6,200 | 4.70% |
| Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
| Jan 1, 2023 | 152,700 | 11,000 | 7.76% |
| Jan 2, 2022 | 141,700 | 7,200 | 5.35% |
| Jan 3, 2021 | 134,500 | 2,300 | 1.74% |
| Dec 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 3, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 327,000 |
| Deutsche Telekom AG | 198,194 |
| Allianz SE | 156,626 |
| Rheinmetall AG | 28,539 |
| Siemens Energy AG | 98,000 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Johnson & Johnson News
- 1 day ago - Johnson & Johnson (JNJ) Welcomes New Board Member, John Morikis - GuruFocus
- 1 day ago - Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors - Wallstreet:Online
- 1 day ago - Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors - Business Wire
- 1 day ago - Johnson & Johnson to Present at Bernstein 2nd Annual Healthcare Forum | JNJ stock news - GuruFocus
- 1 day ago - Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum - Business Wire
- 1 day ago - Johnson & Johnson: All-Time Highs In Sight After Raised Guidance And A Technical Breakout - Seeking Alpha
- 2 days ago - Johnson & Johnson: A Safe Hold, But Lacking Catalysts To Beat The Market - Seeking Alpha
- 2 days ago - Johnson & Johnson (JNJ) Highlights Promising Lung Cancer Treatment Study - GuruFocus